Patient-derived xenograft (PDX) models in basic and translational breast cancer research.
Identifieur interne : 004094 ( Ncbi/Merge ); précédent : 004093; suivant : 004095Patient-derived xenograft (PDX) models in basic and translational breast cancer research.
Auteurs : Lacey E. Dobrolecki [États-Unis] ; Susie D. Airhart [États-Unis] ; Denis G. Alferez [Royaume-Uni] ; Samuel Aparicio [Canada] ; Fariba Behbod [États-Unis] ; Mohamed Bentires-Alj [Suisse] ; Cathrin Brisken [Suisse] ; Carol J. Bult [États-Unis] ; Shirong Cai [États-Unis] ; Robert B. Clarke [Royaume-Uni] ; Heidi Dowst [États-Unis] ; Matthew J. Ellis [États-Unis] ; Eva Gonzalez-Suarez [Espagne] ; Richard D. Iggo [France] ; Peter Kabos [États-Unis] ; Shunqiang Li [États-Unis] ; Geoffrey J. Lindeman [Australie] ; Elisabetta Marangoni [France] ; Aaron Mccoy [États-Unis] ; Funda Meric-Bernstam [États-Unis] ; Helen Piwnica-Worms [États-Unis] ; Marie-France Poupon [France] ; Jorge Reis-Filho [États-Unis] ; Carol A. Sartorius [États-Unis] ; Valentina Scabia [Suisse] ; George Sflomos [Suisse] ; Yizheng Tu [États-Unis] ; François Vaillant [Australie] ; Jane E. Visvader [Australie] ; Alana Welm [États-Unis] ; Max S. Wicha [États-Unis] ; Michael T. Lewis [États-Unis]Source :
- Cancer metastasis reviews [ 1573-7233 ] ; 2016.
Descripteurs français
- KwdFr :
- MESH :
English descriptors
- KwdEn :
- MESH :
Abstract
Patient-derived xenograft (PDX) models of a growing spectrum of cancers are rapidly supplanting long-established traditional cell lines as preferred models for conducting basic and translational preclinical research. In breast cancer, to complement the now curated collection of approximately 45 long-established human breast cancer cell lines, a newly formed consortium of academic laboratories, currently from Europe, Australia, and North America, herein summarizes data on over 500 stably transplantable PDX models representing all three clinical subtypes of breast cancer (ER+, HER2+, and "Triple-negative" (TNBC)). Many of these models are well-characterized with respect to genomic, transcriptomic, and proteomic features, metastatic behavior, and treatment response to a variety of standard-of-care and experimental therapeutics. These stably transplantable PDX lines are generally available for dissemination to laboratories conducting translational research, and contact information for each collection is provided. This review summarizes current experiences related to PDX generation across participating groups, efforts to develop data standards for annotation and dissemination of patient clinical information that does not compromise patient privacy, efforts to develop complementary data standards for annotation of PDX characteristics and biology, and progress toward "credentialing" of PDX models as surrogates to represent individual patients for use in preclinical and co-clinical translational research. In addition, this review highlights important unresolved questions, as well as current limitations, that have hampered more efficient generation of PDX lines and more rapid adoption of PDX use in translational breast cancer research.
DOI: 10.1007/s10555-016-9653-x
PubMed: 28025748
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001401
- to stream PubMed, to step Curation: 001379
- to stream PubMed, to step Checkpoint: 001379
Links to Exploration step
pubmed:28025748Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Patient-derived xenograft (PDX) models in basic and translational breast cancer research.</title>
<author><name sortKey="Dobrolecki, Lacey E" sort="Dobrolecki, Lacey E" uniqKey="Dobrolecki L" first="Lacey E" last="Dobrolecki">Lacey E. Dobrolecki</name>
<affiliation wicri:level="1"><nlm:affiliation>The Lester and Sue Smith Breast Center, Departments of Molecular and Cellular Biology and Radiology, Baylor College of Medicine, Houston,, TX, 77030, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Lester and Sue Smith Breast Center, Departments of Molecular and Cellular Biology and Radiology, Baylor College of Medicine, Houston,, TX, 77030</wicri:regionArea>
<wicri:noRegion>77030</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Airhart, Susie D" sort="Airhart, Susie D" uniqKey="Airhart S" first="Susie D" last="Airhart">Susie D. Airhart</name>
<affiliation wicri:level="1"><nlm:affiliation>The Jackson Laboratory, Bar Harbor, ME, 04609, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Jackson Laboratory, Bar Harbor, ME, 04609</wicri:regionArea>
<wicri:noRegion>04609</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Alferez, Denis G" sort="Alferez, Denis G" uniqKey="Alferez D" first="Denis G" last="Alferez">Denis G. Alferez</name>
<affiliation wicri:level="4"><nlm:affiliation>Breast Cancer Now Research Unit, Division of Molecular and Clinical Cancer Sciences, Manchester Cancer Research Centre, University of Manchester, Wilmslow Road, Manchester, M21 4QL, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Breast Cancer Now Research Unit, Division of Molecular and Clinical Cancer Sciences, Manchester Cancer Research Centre, University of Manchester, Wilmslow Road, Manchester, M21 4QL</wicri:regionArea>
<orgName type="university">Université de Manchester</orgName>
<placeName><settlement type="city">Manchester</settlement>
<region type="nation">Angleterre</region>
<region nuts="2" type="region">Grand Manchester</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Aparicio, Samuel" sort="Aparicio, Samuel" uniqKey="Aparicio S" first="Samuel" last="Aparicio">Samuel Aparicio</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pathology and Laboratory Medicine, BC Cancer Agency, 675 W10th Avenue, Vancouver, V6R 3A6, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Pathology and Laboratory Medicine, BC Cancer Agency, 675 W10th Avenue, Vancouver, V6R 3A6</wicri:regionArea>
<wicri:noRegion>V6R 3A6</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Behbod, Fariba" sort="Behbod, Fariba" uniqKey="Behbod F" first="Fariba" last="Behbod">Fariba Behbod</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pathology, University of Kansas Medical Center, |3901 Rainbow Blvd, WHE 1005B, Kansas City, KS, 66160, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pathology, University of Kansas Medical Center, |3901 Rainbow Blvd, WHE 1005B, Kansas City, KS, 66160</wicri:regionArea>
<wicri:noRegion>66160</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bentires Alj, Mohamed" sort="Bentires Alj, Mohamed" uniqKey="Bentires Alj M" first="Mohamed" last="Bentires-Alj">Mohamed Bentires-Alj</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Biomedicine, University of Basel, University Hospital Basel, Lab 306, Hebelstrasse 20, CH-4031, Basel, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Department of Biomedicine, University of Basel, University Hospital Basel, Lab 306, Hebelstrasse 20, CH-4031, Basel</wicri:regionArea>
<wicri:noRegion>Basel</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Brisken, Cathrin" sort="Brisken, Cathrin" uniqKey="Brisken C" first="Cathrin" last="Brisken">Cathrin Brisken</name>
<affiliation wicri:level="3"><nlm:affiliation>School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), ISREC-Swiss Institute for Experimental Cancer Research, SV2.832 Station 19, 1015, Lausanne, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), ISREC-Swiss Institute for Experimental Cancer Research, SV2.832 Station 19, 1015, Lausanne</wicri:regionArea>
<placeName><settlement type="city">Lausanne</settlement>
<region nuts="3" type="region">Canton de Vaud</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bult, Carol J" sort="Bult, Carol J" uniqKey="Bult C" first="Carol J" last="Bult">Carol J. Bult</name>
<affiliation wicri:level="1"><nlm:affiliation>The Jackson Laboratory, Bar Harbor, ME, 04609, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Jackson Laboratory, Bar Harbor, ME, 04609</wicri:regionArea>
<wicri:noRegion>04609</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Cai, Shirong" sort="Cai, Shirong" uniqKey="Cai S" first="Shirong" last="Cai">Shirong Cai</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, 77030</wicri:regionArea>
<wicri:noRegion>77030</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Clarke, Robert B" sort="Clarke, Robert B" uniqKey="Clarke R" first="Robert B" last="Clarke">Robert B. Clarke</name>
<affiliation wicri:level="4"><nlm:affiliation>Breast Cancer Now Research Unit, Division of Molecular and Clinical Cancer Sciences, Manchester Cancer Research Centre, University of Manchester, Wilmslow Road, Manchester, M21 4QL, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Breast Cancer Now Research Unit, Division of Molecular and Clinical Cancer Sciences, Manchester Cancer Research Centre, University of Manchester, Wilmslow Road, Manchester, M21 4QL</wicri:regionArea>
<orgName type="university">Université de Manchester</orgName>
<placeName><settlement type="city">Manchester</settlement>
<region type="nation">Angleterre</region>
<region nuts="2" type="region">Grand Manchester</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Dowst, Heidi" sort="Dowst, Heidi" uniqKey="Dowst H" first="Heidi" last="Dowst">Heidi Dowst</name>
<affiliation wicri:level="1"><nlm:affiliation>Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, 77030, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, 77030</wicri:regionArea>
<wicri:noRegion>77030</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ellis, Matthew J" sort="Ellis, Matthew J" uniqKey="Ellis M" first="Matthew J" last="Ellis">Matthew J. Ellis</name>
<affiliation wicri:level="1"><nlm:affiliation>The Lester and Sue Smith Breast Center, Departments of Molecular and Cellular Biology and Radiology, Baylor College of Medicine, Houston,, TX, 77030, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Lester and Sue Smith Breast Center, Departments of Molecular and Cellular Biology and Radiology, Baylor College of Medicine, Houston,, TX, 77030</wicri:regionArea>
<wicri:noRegion>77030</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gonzalez Suarez, Eva" sort="Gonzalez Suarez, Eva" uniqKey="Gonzalez Suarez E" first="Eva" last="Gonzalez-Suarez">Eva Gonzalez-Suarez</name>
<affiliation wicri:level="3"><nlm:affiliation>Cancer Epigenetics and Biology Program, PEBC, Bellvitge Institute for Biomedical Research, IDIBELL, Av. Gran Via de L'Hospitalet, 199-203, 08908 L'Hospitalet de Llobregat, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Cancer Epigenetics and Biology Program, PEBC, Bellvitge Institute for Biomedical Research, IDIBELL, Av. Gran Via de L'Hospitalet, 199-203, 08908 L'Hospitalet de Llobregat, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Iggo, Richard D" sort="Iggo, Richard D" uniqKey="Iggo R" first="Richard D" last="Iggo">Richard D. Iggo</name>
<affiliation wicri:level="3"><nlm:affiliation>INSERM U1218, Bergonié Cancer Institute, 229 cours de l'Argonne, 33076, Bordeaux, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>INSERM U1218, Bergonié Cancer Institute, 229 cours de l'Argonne, 33076, Bordeaux</wicri:regionArea>
<placeName><region type="region" nuts="2">Nouvelle-Aquitaine</region>
<region type="old region" nuts="2">Aquitaine</region>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kabos, Peter" sort="Kabos, Peter" uniqKey="Kabos P" first="Peter" last="Kabos">Peter Kabos</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045</wicri:regionArea>
<wicri:noRegion>80045</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Li, Shunqiang" sort="Li, Shunqiang" uniqKey="Li S" first="Shunqiang" last="Li">Shunqiang Li</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine, Washington University, St. Louis, MO, 63130, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Internal Medicine, Washington University, St. Louis, MO, 63130</wicri:regionArea>
<wicri:noRegion>63130</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lindeman, Geoffrey J" sort="Lindeman, Geoffrey J" uniqKey="Lindeman G" first="Geoffrey J" last="Lindeman">Geoffrey J. Lindeman</name>
<affiliation wicri:level="1"><nlm:affiliation>Stem Cells and Cancer Division, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC, 3052, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Stem Cells and Cancer Division, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC, 3052</wicri:regionArea>
<wicri:noRegion>3052</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Marangoni, Elisabetta" sort="Marangoni, Elisabetta" uniqKey="Marangoni E" first="Elisabetta" last="Marangoni">Elisabetta Marangoni</name>
<affiliation wicri:level="3"><nlm:affiliation>Translational Research Department, Institut Curie, 26, rue d'Ulm, 75005, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Translational Research Department, Institut Curie, 26, rue d'Ulm, 75005, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
<region type="région" nuts="2">Île-de-France</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Mccoy, Aaron" sort="Mccoy, Aaron" uniqKey="Mccoy A" first="Aaron" last="Mccoy">Aaron Mccoy</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, 77030</wicri:regionArea>
<wicri:noRegion>77030</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Meric Bernstam, Funda" sort="Meric Bernstam, Funda" uniqKey="Meric Bernstam F" first="Funda" last="Meric-Bernstam">Funda Meric-Bernstam</name>
<affiliation wicri:level="1"><nlm:affiliation>Departments of Investigational Cancer Therapeutics and Breast Surgical Oncology, UT M. D. Anderson Cancer Center, Houston, TX, 77030, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Departments of Investigational Cancer Therapeutics and Breast Surgical Oncology, UT M. D. Anderson Cancer Center, Houston, TX, 77030</wicri:regionArea>
<wicri:noRegion>77030</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Piwnica Worms, Helen" sort="Piwnica Worms, Helen" uniqKey="Piwnica Worms H" first="Helen" last="Piwnica-Worms">Helen Piwnica-Worms</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, 77030</wicri:regionArea>
<wicri:noRegion>77030</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Poupon, Marie France" sort="Poupon, Marie France" uniqKey="Poupon M" first="Marie-France" last="Poupon">Marie-France Poupon</name>
<affiliation wicri:level="1"><nlm:affiliation>Founder and Scientific Advisor, XenTech SA, Genopole, 4 rue Pierre Fontaine, 91000, Evry, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Founder and Scientific Advisor, XenTech SA, Genopole, 4 rue Pierre Fontaine, 91000, Evry</wicri:regionArea>
<wicri:noRegion>91000, Evry</wicri:noRegion>
<wicri:noRegion>91000, Evry</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Reis Filho, Jorge" sort="Reis Filho, Jorge" uniqKey="Reis Filho J" first="Jorge" last="Reis-Filho">Jorge Reis-Filho</name>
<affiliation wicri:level="2"><nlm:affiliation>Director of Experimental Pathology, Department of Pathology, Affiliate Member, Human Oncology and Pathogenesis Program, and Center for Computational Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Director of Experimental Pathology, Department of Pathology, Affiliate Member, Human Oncology and Pathogenesis Program, and Center for Computational Biology, Memorial Sloan Kettering Cancer Center, New York, NY</wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sartorius, Carol A" sort="Sartorius, Carol A" uniqKey="Sartorius C" first="Carol A" last="Sartorius">Carol A. Sartorius</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045</wicri:regionArea>
<wicri:noRegion>80045</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Scabia, Valentina" sort="Scabia, Valentina" uniqKey="Scabia V" first="Valentina" last="Scabia">Valentina Scabia</name>
<affiliation wicri:level="3"><nlm:affiliation>School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), ISREC-Swiss Institute for Experimental Cancer Research, SV2.832 Station 19, 1015, Lausanne, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), ISREC-Swiss Institute for Experimental Cancer Research, SV2.832 Station 19, 1015, Lausanne</wicri:regionArea>
<placeName><settlement type="city">Lausanne</settlement>
<region nuts="3" type="region">Canton de Vaud</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sflomos, George" sort="Sflomos, George" uniqKey="Sflomos G" first="George" last="Sflomos">George Sflomos</name>
<affiliation wicri:level="3"><nlm:affiliation>School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), ISREC-Swiss Institute for Experimental Cancer Research, SV2.832 Station 19, 1015, Lausanne, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), ISREC-Swiss Institute for Experimental Cancer Research, SV2.832 Station 19, 1015, Lausanne</wicri:regionArea>
<placeName><settlement type="city">Lausanne</settlement>
<region nuts="3" type="region">Canton de Vaud</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Tu, Yizheng" sort="Tu, Yizheng" uniqKey="Tu Y" first="Yizheng" last="Tu">Yizheng Tu</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, 77030</wicri:regionArea>
<wicri:noRegion>77030</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Vaillant, Francois" sort="Vaillant, Francois" uniqKey="Vaillant F" first="François" last="Vaillant">François Vaillant</name>
<affiliation wicri:level="1"><nlm:affiliation>Stem Cells and Cancer Division, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC, 3052, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Stem Cells and Cancer Division, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC, 3052</wicri:regionArea>
<wicri:noRegion>3052</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Visvader, Jane E" sort="Visvader, Jane E" uniqKey="Visvader J" first="Jane E" last="Visvader">Jane E. Visvader</name>
<affiliation wicri:level="1"><nlm:affiliation>Stem Cells and Cancer Division, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC, 3052, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Stem Cells and Cancer Division, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC, 3052</wicri:regionArea>
<wicri:noRegion>3052</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Welm, Alana" sort="Welm, Alana" uniqKey="Welm A" first="Alana" last="Welm">Alana Welm</name>
<affiliation wicri:level="1"><nlm:affiliation>Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT, 84112, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT, 84112</wicri:regionArea>
<wicri:noRegion>84112</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Wicha, Max S" sort="Wicha, Max S" uniqKey="Wicha M" first="Max S" last="Wicha">Max S. Wicha</name>
<affiliation wicri:level="1"><nlm:affiliation>Madeline and Sidney Forbes Professor of Oncology, Director, Forbes Institute for Cancer Discovery, NCRC 26-335S, SPC 2800 2800 Plymouth Rd, Ann Arbor, MI, 48109-2800, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Madeline and Sidney Forbes Professor of Oncology, Director, Forbes Institute for Cancer Discovery, NCRC 26-335S, SPC 2800 2800 Plymouth Rd, Ann Arbor, MI, 48109-2800</wicri:regionArea>
<wicri:noRegion>48109-2800</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lewis, Michael T" sort="Lewis, Michael T" uniqKey="Lewis M" first="Michael T" last="Lewis">Michael T. Lewis</name>
<affiliation wicri:level="1"><nlm:affiliation>The Lester and Sue Smith Breast Center, Departments of Molecular and Cellular Biology and Radiology, Baylor College of Medicine, Houston,, TX, 77030, USA. mtlewis@bcm.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Lester and Sue Smith Breast Center, Departments of Molecular and Cellular Biology and Radiology, Baylor College of Medicine, Houston,, TX, 77030</wicri:regionArea>
<wicri:noRegion>77030</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:28025748</idno>
<idno type="pmid">28025748</idno>
<idno type="doi">10.1007/s10555-016-9653-x</idno>
<idno type="wicri:Area/PubMed/Corpus">001401</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001401</idno>
<idno type="wicri:Area/PubMed/Curation">001379</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001379</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001379</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001379</idno>
<idno type="wicri:Area/Ncbi/Merge">004094</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Patient-derived xenograft (PDX) models in basic and translational breast cancer research.</title>
<author><name sortKey="Dobrolecki, Lacey E" sort="Dobrolecki, Lacey E" uniqKey="Dobrolecki L" first="Lacey E" last="Dobrolecki">Lacey E. Dobrolecki</name>
<affiliation wicri:level="1"><nlm:affiliation>The Lester and Sue Smith Breast Center, Departments of Molecular and Cellular Biology and Radiology, Baylor College of Medicine, Houston,, TX, 77030, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Lester and Sue Smith Breast Center, Departments of Molecular and Cellular Biology and Radiology, Baylor College of Medicine, Houston,, TX, 77030</wicri:regionArea>
<wicri:noRegion>77030</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Airhart, Susie D" sort="Airhart, Susie D" uniqKey="Airhart S" first="Susie D" last="Airhart">Susie D. Airhart</name>
<affiliation wicri:level="1"><nlm:affiliation>The Jackson Laboratory, Bar Harbor, ME, 04609, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Jackson Laboratory, Bar Harbor, ME, 04609</wicri:regionArea>
<wicri:noRegion>04609</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Alferez, Denis G" sort="Alferez, Denis G" uniqKey="Alferez D" first="Denis G" last="Alferez">Denis G. Alferez</name>
<affiliation wicri:level="4"><nlm:affiliation>Breast Cancer Now Research Unit, Division of Molecular and Clinical Cancer Sciences, Manchester Cancer Research Centre, University of Manchester, Wilmslow Road, Manchester, M21 4QL, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Breast Cancer Now Research Unit, Division of Molecular and Clinical Cancer Sciences, Manchester Cancer Research Centre, University of Manchester, Wilmslow Road, Manchester, M21 4QL</wicri:regionArea>
<orgName type="university">Université de Manchester</orgName>
<placeName><settlement type="city">Manchester</settlement>
<region type="nation">Angleterre</region>
<region nuts="2" type="region">Grand Manchester</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Aparicio, Samuel" sort="Aparicio, Samuel" uniqKey="Aparicio S" first="Samuel" last="Aparicio">Samuel Aparicio</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pathology and Laboratory Medicine, BC Cancer Agency, 675 W10th Avenue, Vancouver, V6R 3A6, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Pathology and Laboratory Medicine, BC Cancer Agency, 675 W10th Avenue, Vancouver, V6R 3A6</wicri:regionArea>
<wicri:noRegion>V6R 3A6</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Behbod, Fariba" sort="Behbod, Fariba" uniqKey="Behbod F" first="Fariba" last="Behbod">Fariba Behbod</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pathology, University of Kansas Medical Center, |3901 Rainbow Blvd, WHE 1005B, Kansas City, KS, 66160, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pathology, University of Kansas Medical Center, |3901 Rainbow Blvd, WHE 1005B, Kansas City, KS, 66160</wicri:regionArea>
<wicri:noRegion>66160</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bentires Alj, Mohamed" sort="Bentires Alj, Mohamed" uniqKey="Bentires Alj M" first="Mohamed" last="Bentires-Alj">Mohamed Bentires-Alj</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Biomedicine, University of Basel, University Hospital Basel, Lab 306, Hebelstrasse 20, CH-4031, Basel, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Department of Biomedicine, University of Basel, University Hospital Basel, Lab 306, Hebelstrasse 20, CH-4031, Basel</wicri:regionArea>
<wicri:noRegion>Basel</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Brisken, Cathrin" sort="Brisken, Cathrin" uniqKey="Brisken C" first="Cathrin" last="Brisken">Cathrin Brisken</name>
<affiliation wicri:level="3"><nlm:affiliation>School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), ISREC-Swiss Institute for Experimental Cancer Research, SV2.832 Station 19, 1015, Lausanne, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), ISREC-Swiss Institute for Experimental Cancer Research, SV2.832 Station 19, 1015, Lausanne</wicri:regionArea>
<placeName><settlement type="city">Lausanne</settlement>
<region nuts="3" type="region">Canton de Vaud</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bult, Carol J" sort="Bult, Carol J" uniqKey="Bult C" first="Carol J" last="Bult">Carol J. Bult</name>
<affiliation wicri:level="1"><nlm:affiliation>The Jackson Laboratory, Bar Harbor, ME, 04609, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Jackson Laboratory, Bar Harbor, ME, 04609</wicri:regionArea>
<wicri:noRegion>04609</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Cai, Shirong" sort="Cai, Shirong" uniqKey="Cai S" first="Shirong" last="Cai">Shirong Cai</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, 77030</wicri:regionArea>
<wicri:noRegion>77030</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Clarke, Robert B" sort="Clarke, Robert B" uniqKey="Clarke R" first="Robert B" last="Clarke">Robert B. Clarke</name>
<affiliation wicri:level="4"><nlm:affiliation>Breast Cancer Now Research Unit, Division of Molecular and Clinical Cancer Sciences, Manchester Cancer Research Centre, University of Manchester, Wilmslow Road, Manchester, M21 4QL, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Breast Cancer Now Research Unit, Division of Molecular and Clinical Cancer Sciences, Manchester Cancer Research Centre, University of Manchester, Wilmslow Road, Manchester, M21 4QL</wicri:regionArea>
<orgName type="university">Université de Manchester</orgName>
<placeName><settlement type="city">Manchester</settlement>
<region type="nation">Angleterre</region>
<region nuts="2" type="region">Grand Manchester</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Dowst, Heidi" sort="Dowst, Heidi" uniqKey="Dowst H" first="Heidi" last="Dowst">Heidi Dowst</name>
<affiliation wicri:level="1"><nlm:affiliation>Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, 77030, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, 77030</wicri:regionArea>
<wicri:noRegion>77030</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ellis, Matthew J" sort="Ellis, Matthew J" uniqKey="Ellis M" first="Matthew J" last="Ellis">Matthew J. Ellis</name>
<affiliation wicri:level="1"><nlm:affiliation>The Lester and Sue Smith Breast Center, Departments of Molecular and Cellular Biology and Radiology, Baylor College of Medicine, Houston,, TX, 77030, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Lester and Sue Smith Breast Center, Departments of Molecular and Cellular Biology and Radiology, Baylor College of Medicine, Houston,, TX, 77030</wicri:regionArea>
<wicri:noRegion>77030</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gonzalez Suarez, Eva" sort="Gonzalez Suarez, Eva" uniqKey="Gonzalez Suarez E" first="Eva" last="Gonzalez-Suarez">Eva Gonzalez-Suarez</name>
<affiliation wicri:level="3"><nlm:affiliation>Cancer Epigenetics and Biology Program, PEBC, Bellvitge Institute for Biomedical Research, IDIBELL, Av. Gran Via de L'Hospitalet, 199-203, 08908 L'Hospitalet de Llobregat, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Cancer Epigenetics and Biology Program, PEBC, Bellvitge Institute for Biomedical Research, IDIBELL, Av. Gran Via de L'Hospitalet, 199-203, 08908 L'Hospitalet de Llobregat, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Iggo, Richard D" sort="Iggo, Richard D" uniqKey="Iggo R" first="Richard D" last="Iggo">Richard D. Iggo</name>
<affiliation wicri:level="3"><nlm:affiliation>INSERM U1218, Bergonié Cancer Institute, 229 cours de l'Argonne, 33076, Bordeaux, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>INSERM U1218, Bergonié Cancer Institute, 229 cours de l'Argonne, 33076, Bordeaux</wicri:regionArea>
<placeName><region type="region" nuts="2">Nouvelle-Aquitaine</region>
<region type="old region" nuts="2">Aquitaine</region>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kabos, Peter" sort="Kabos, Peter" uniqKey="Kabos P" first="Peter" last="Kabos">Peter Kabos</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045</wicri:regionArea>
<wicri:noRegion>80045</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Li, Shunqiang" sort="Li, Shunqiang" uniqKey="Li S" first="Shunqiang" last="Li">Shunqiang Li</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine, Washington University, St. Louis, MO, 63130, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Internal Medicine, Washington University, St. Louis, MO, 63130</wicri:regionArea>
<wicri:noRegion>63130</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lindeman, Geoffrey J" sort="Lindeman, Geoffrey J" uniqKey="Lindeman G" first="Geoffrey J" last="Lindeman">Geoffrey J. Lindeman</name>
<affiliation wicri:level="1"><nlm:affiliation>Stem Cells and Cancer Division, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC, 3052, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Stem Cells and Cancer Division, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC, 3052</wicri:regionArea>
<wicri:noRegion>3052</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Marangoni, Elisabetta" sort="Marangoni, Elisabetta" uniqKey="Marangoni E" first="Elisabetta" last="Marangoni">Elisabetta Marangoni</name>
<affiliation wicri:level="3"><nlm:affiliation>Translational Research Department, Institut Curie, 26, rue d'Ulm, 75005, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Translational Research Department, Institut Curie, 26, rue d'Ulm, 75005, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
<region type="région" nuts="2">Île-de-France</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Mccoy, Aaron" sort="Mccoy, Aaron" uniqKey="Mccoy A" first="Aaron" last="Mccoy">Aaron Mccoy</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, 77030</wicri:regionArea>
<wicri:noRegion>77030</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Meric Bernstam, Funda" sort="Meric Bernstam, Funda" uniqKey="Meric Bernstam F" first="Funda" last="Meric-Bernstam">Funda Meric-Bernstam</name>
<affiliation wicri:level="1"><nlm:affiliation>Departments of Investigational Cancer Therapeutics and Breast Surgical Oncology, UT M. D. Anderson Cancer Center, Houston, TX, 77030, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Departments of Investigational Cancer Therapeutics and Breast Surgical Oncology, UT M. D. Anderson Cancer Center, Houston, TX, 77030</wicri:regionArea>
<wicri:noRegion>77030</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Piwnica Worms, Helen" sort="Piwnica Worms, Helen" uniqKey="Piwnica Worms H" first="Helen" last="Piwnica-Worms">Helen Piwnica-Worms</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, 77030</wicri:regionArea>
<wicri:noRegion>77030</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Poupon, Marie France" sort="Poupon, Marie France" uniqKey="Poupon M" first="Marie-France" last="Poupon">Marie-France Poupon</name>
<affiliation wicri:level="1"><nlm:affiliation>Founder and Scientific Advisor, XenTech SA, Genopole, 4 rue Pierre Fontaine, 91000, Evry, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Founder and Scientific Advisor, XenTech SA, Genopole, 4 rue Pierre Fontaine, 91000, Evry</wicri:regionArea>
<wicri:noRegion>91000, Evry</wicri:noRegion>
<wicri:noRegion>91000, Evry</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Reis Filho, Jorge" sort="Reis Filho, Jorge" uniqKey="Reis Filho J" first="Jorge" last="Reis-Filho">Jorge Reis-Filho</name>
<affiliation wicri:level="2"><nlm:affiliation>Director of Experimental Pathology, Department of Pathology, Affiliate Member, Human Oncology and Pathogenesis Program, and Center for Computational Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Director of Experimental Pathology, Department of Pathology, Affiliate Member, Human Oncology and Pathogenesis Program, and Center for Computational Biology, Memorial Sloan Kettering Cancer Center, New York, NY</wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sartorius, Carol A" sort="Sartorius, Carol A" uniqKey="Sartorius C" first="Carol A" last="Sartorius">Carol A. Sartorius</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045</wicri:regionArea>
<wicri:noRegion>80045</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Scabia, Valentina" sort="Scabia, Valentina" uniqKey="Scabia V" first="Valentina" last="Scabia">Valentina Scabia</name>
<affiliation wicri:level="3"><nlm:affiliation>School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), ISREC-Swiss Institute for Experimental Cancer Research, SV2.832 Station 19, 1015, Lausanne, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), ISREC-Swiss Institute for Experimental Cancer Research, SV2.832 Station 19, 1015, Lausanne</wicri:regionArea>
<placeName><settlement type="city">Lausanne</settlement>
<region nuts="3" type="region">Canton de Vaud</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sflomos, George" sort="Sflomos, George" uniqKey="Sflomos G" first="George" last="Sflomos">George Sflomos</name>
<affiliation wicri:level="3"><nlm:affiliation>School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), ISREC-Swiss Institute for Experimental Cancer Research, SV2.832 Station 19, 1015, Lausanne, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), ISREC-Swiss Institute for Experimental Cancer Research, SV2.832 Station 19, 1015, Lausanne</wicri:regionArea>
<placeName><settlement type="city">Lausanne</settlement>
<region nuts="3" type="region">Canton de Vaud</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Tu, Yizheng" sort="Tu, Yizheng" uniqKey="Tu Y" first="Yizheng" last="Tu">Yizheng Tu</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, 77030</wicri:regionArea>
<wicri:noRegion>77030</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Vaillant, Francois" sort="Vaillant, Francois" uniqKey="Vaillant F" first="François" last="Vaillant">François Vaillant</name>
<affiliation wicri:level="1"><nlm:affiliation>Stem Cells and Cancer Division, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC, 3052, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Stem Cells and Cancer Division, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC, 3052</wicri:regionArea>
<wicri:noRegion>3052</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Visvader, Jane E" sort="Visvader, Jane E" uniqKey="Visvader J" first="Jane E" last="Visvader">Jane E. Visvader</name>
<affiliation wicri:level="1"><nlm:affiliation>Stem Cells and Cancer Division, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC, 3052, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Stem Cells and Cancer Division, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC, 3052</wicri:regionArea>
<wicri:noRegion>3052</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Welm, Alana" sort="Welm, Alana" uniqKey="Welm A" first="Alana" last="Welm">Alana Welm</name>
<affiliation wicri:level="1"><nlm:affiliation>Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT, 84112, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT, 84112</wicri:regionArea>
<wicri:noRegion>84112</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Wicha, Max S" sort="Wicha, Max S" uniqKey="Wicha M" first="Max S" last="Wicha">Max S. Wicha</name>
<affiliation wicri:level="1"><nlm:affiliation>Madeline and Sidney Forbes Professor of Oncology, Director, Forbes Institute for Cancer Discovery, NCRC 26-335S, SPC 2800 2800 Plymouth Rd, Ann Arbor, MI, 48109-2800, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Madeline and Sidney Forbes Professor of Oncology, Director, Forbes Institute for Cancer Discovery, NCRC 26-335S, SPC 2800 2800 Plymouth Rd, Ann Arbor, MI, 48109-2800</wicri:regionArea>
<wicri:noRegion>48109-2800</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lewis, Michael T" sort="Lewis, Michael T" uniqKey="Lewis M" first="Michael T" last="Lewis">Michael T. Lewis</name>
<affiliation wicri:level="1"><nlm:affiliation>The Lester and Sue Smith Breast Center, Departments of Molecular and Cellular Biology and Radiology, Baylor College of Medicine, Houston,, TX, 77030, USA. mtlewis@bcm.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Lester and Sue Smith Breast Center, Departments of Molecular and Cellular Biology and Radiology, Baylor College of Medicine, Houston,, TX, 77030</wicri:regionArea>
<wicri:noRegion>77030</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Cancer metastasis reviews</title>
<idno type="eISSN">1573-7233</idno>
<imprint><date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Breast Neoplasms (pathology)</term>
<term>Disease Models, Animal</term>
<term>Female</term>
<term>Heterografts</term>
<term>Humans</term>
<term>Mice, Inbred NOD</term>
<term>Mice, SCID</term>
<term>Neoplasm Transplantation</term>
<term>Translational Medical Research</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term>
<term>Femelle</term>
<term>Humains</term>
<term>Hétérogreffes</term>
<term>Modèles animaux de maladie humaine</term>
<term>Recherche médicale translationnelle</term>
<term>Souris SCID</term>
<term>Souris de lignée NOD</term>
<term>Transplantation tumorale</term>
<term>Tumeurs du sein (anatomopathologie)</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Disease Models, Animal</term>
<term>Female</term>
<term>Heterografts</term>
<term>Humans</term>
<term>Mice, Inbred NOD</term>
<term>Mice, SCID</term>
<term>Neoplasm Transplantation</term>
<term>Translational Medical Research</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Animaux</term>
<term>Femelle</term>
<term>Humains</term>
<term>Hétérogreffes</term>
<term>Modèles animaux de maladie humaine</term>
<term>Recherche médicale translationnelle</term>
<term>Souris SCID</term>
<term>Souris de lignée NOD</term>
<term>Transplantation tumorale</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Patient-derived xenograft (PDX) models of a growing spectrum of cancers are rapidly supplanting long-established traditional cell lines as preferred models for conducting basic and translational preclinical research. In breast cancer, to complement the now curated collection of approximately 45 long-established human breast cancer cell lines, a newly formed consortium of academic laboratories, currently from Europe, Australia, and North America, herein summarizes data on over 500 stably transplantable PDX models representing all three clinical subtypes of breast cancer (ER+, HER2+, and "Triple-negative" (TNBC)). Many of these models are well-characterized with respect to genomic, transcriptomic, and proteomic features, metastatic behavior, and treatment response to a variety of standard-of-care and experimental therapeutics. These stably transplantable PDX lines are generally available for dissemination to laboratories conducting translational research, and contact information for each collection is provided. This review summarizes current experiences related to PDX generation across participating groups, efforts to develop data standards for annotation and dissemination of patient clinical information that does not compromise patient privacy, efforts to develop complementary data standards for annotation of PDX characteristics and biology, and progress toward "credentialing" of PDX models as surrogates to represent individual patients for use in preclinical and co-clinical translational research. In addition, this review highlights important unresolved questions, as well as current limitations, that have hampered more efficient generation of PDX lines and more rapid adoption of PDX use in translational breast cancer research.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28025748</PMID>
<DateCreated><Year>2016</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted><Year>2017</Year>
<Month>10</Month>
<Day>31</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>10</Month>
<Day>31</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1573-7233</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>35</Volume>
<Issue>4</Issue>
<PubDate><Year>2016</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Cancer metastasis reviews</Title>
<ISOAbbreviation>Cancer Metastasis Rev.</ISOAbbreviation>
</Journal>
<ArticleTitle>Patient-derived xenograft (PDX) models in basic and translational breast cancer research.</ArticleTitle>
<Pagination><MedlinePgn>547-573</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s10555-016-9653-x</ELocationID>
<Abstract><AbstractText>Patient-derived xenograft (PDX) models of a growing spectrum of cancers are rapidly supplanting long-established traditional cell lines as preferred models for conducting basic and translational preclinical research. In breast cancer, to complement the now curated collection of approximately 45 long-established human breast cancer cell lines, a newly formed consortium of academic laboratories, currently from Europe, Australia, and North America, herein summarizes data on over 500 stably transplantable PDX models representing all three clinical subtypes of breast cancer (ER+, HER2+, and "Triple-negative" (TNBC)). Many of these models are well-characterized with respect to genomic, transcriptomic, and proteomic features, metastatic behavior, and treatment response to a variety of standard-of-care and experimental therapeutics. These stably transplantable PDX lines are generally available for dissemination to laboratories conducting translational research, and contact information for each collection is provided. This review summarizes current experiences related to PDX generation across participating groups, efforts to develop data standards for annotation and dissemination of patient clinical information that does not compromise patient privacy, efforts to develop complementary data standards for annotation of PDX characteristics and biology, and progress toward "credentialing" of PDX models as surrogates to represent individual patients for use in preclinical and co-clinical translational research. In addition, this review highlights important unresolved questions, as well as current limitations, that have hampered more efficient generation of PDX lines and more rapid adoption of PDX use in translational breast cancer research.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dobrolecki</LastName>
<ForeName>Lacey E</ForeName>
<Initials>LE</Initials>
<AffiliationInfo><Affiliation>The Lester and Sue Smith Breast Center, Departments of Molecular and Cellular Biology and Radiology, Baylor College of Medicine, Houston,, TX, 77030, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Airhart</LastName>
<ForeName>Susie D</ForeName>
<Initials>SD</Initials>
<AffiliationInfo><Affiliation>The Jackson Laboratory, Bar Harbor, ME, 04609, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Alferez</LastName>
<ForeName>Denis G</ForeName>
<Initials>DG</Initials>
<AffiliationInfo><Affiliation>Breast Cancer Now Research Unit, Division of Molecular and Clinical Cancer Sciences, Manchester Cancer Research Centre, University of Manchester, Wilmslow Road, Manchester, M21 4QL, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Aparicio</LastName>
<ForeName>Samuel</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, BC Cancer Agency, 675 W10th Avenue, Vancouver, V6R 3A6, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Behbod</LastName>
<ForeName>Fariba</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>Department of Pathology, University of Kansas Medical Center, |3901 Rainbow Blvd, WHE 1005B, Kansas City, KS, 66160, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bentires-Alj</LastName>
<ForeName>Mohamed</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Department of Biomedicine, University of Basel, University Hospital Basel, Lab 306, Hebelstrasse 20, CH-4031, Basel, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Brisken</LastName>
<ForeName>Cathrin</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), ISREC-Swiss Institute for Experimental Cancer Research, SV2.832 Station 19, 1015, Lausanne, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bult</LastName>
<ForeName>Carol J</ForeName>
<Initials>CJ</Initials>
<AffiliationInfo><Affiliation>The Jackson Laboratory, Bar Harbor, ME, 04609, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Cai</LastName>
<ForeName>Shirong</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Clarke</LastName>
<ForeName>Robert B</ForeName>
<Initials>RB</Initials>
<AffiliationInfo><Affiliation>Breast Cancer Now Research Unit, Division of Molecular and Clinical Cancer Sciences, Manchester Cancer Research Centre, University of Manchester, Wilmslow Road, Manchester, M21 4QL, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Dowst</LastName>
<ForeName>Heidi</ForeName>
<Initials>H</Initials>
<AffiliationInfo><Affiliation>Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, 77030, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ellis</LastName>
<ForeName>Matthew J</ForeName>
<Initials>MJ</Initials>
<AffiliationInfo><Affiliation>The Lester and Sue Smith Breast Center, Departments of Molecular and Cellular Biology and Radiology, Baylor College of Medicine, Houston,, TX, 77030, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Gonzalez-Suarez</LastName>
<ForeName>Eva</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Cancer Epigenetics and Biology Program, PEBC, Bellvitge Institute for Biomedical Research, IDIBELL, Av. Gran Via de L'Hospitalet, 199-203, 08908 L'Hospitalet de Llobregat, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Iggo</LastName>
<ForeName>Richard D</ForeName>
<Initials>RD</Initials>
<AffiliationInfo><Affiliation>INSERM U1218, Bergonié Cancer Institute, 229 cours de l'Argonne, 33076, Bordeaux, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kabos</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Li</LastName>
<ForeName>Shunqiang</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Department of Internal Medicine, Washington University, St. Louis, MO, 63130, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Lindeman</LastName>
<ForeName>Geoffrey J</ForeName>
<Initials>GJ</Initials>
<AffiliationInfo><Affiliation>Stem Cells and Cancer Division, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC, 3052, Australia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Medicine, The University of Melbourne, Parkville, VIC, 3010, Australia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Familial Cancer Centre, Royal Melbourne Hospital, Peter MacCallum Cancer Centre, Grattan St, Parkville, VIC, 3050, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Marangoni</LastName>
<ForeName>Elisabetta</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Translational Research Department, Institut Curie, 26, rue d'Ulm, 75005, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>McCoy</LastName>
<ForeName>Aaron</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Meric-Bernstam</LastName>
<ForeName>Funda</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>Departments of Investigational Cancer Therapeutics and Breast Surgical Oncology, UT M. D. Anderson Cancer Center, Houston, TX, 77030, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Piwnica-Worms</LastName>
<ForeName>Helen</ForeName>
<Initials>H</Initials>
<AffiliationInfo><Affiliation>Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Poupon</LastName>
<ForeName>Marie-France</ForeName>
<Initials>MF</Initials>
<AffiliationInfo><Affiliation>Founder and Scientific Advisor, XenTech SA, Genopole, 4 rue Pierre Fontaine, 91000, Evry, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Reis-Filho</LastName>
<ForeName>Jorge</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Director of Experimental Pathology, Department of Pathology, Affiliate Member, Human Oncology and Pathogenesis Program, and Center for Computational Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sartorius</LastName>
<ForeName>Carol A</ForeName>
<Initials>CA</Initials>
<AffiliationInfo><Affiliation>Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Scabia</LastName>
<ForeName>Valentina</ForeName>
<Initials>V</Initials>
<AffiliationInfo><Affiliation>School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), ISREC-Swiss Institute for Experimental Cancer Research, SV2.832 Station 19, 1015, Lausanne, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sflomos</LastName>
<ForeName>George</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), ISREC-Swiss Institute for Experimental Cancer Research, SV2.832 Station 19, 1015, Lausanne, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Tu</LastName>
<ForeName>Yizheng</ForeName>
<Initials>Y</Initials>
<AffiliationInfo><Affiliation>Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Vaillant</LastName>
<ForeName>François</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>Stem Cells and Cancer Division, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC, 3052, Australia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Medical Biology, University of Melbourne, Parkville, VIC, 3010, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Visvader</LastName>
<ForeName>Jane E</ForeName>
<Initials>JE</Initials>
<AffiliationInfo><Affiliation>Stem Cells and Cancer Division, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC, 3052, Australia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Medical Biology, University of Melbourne, Parkville, VIC, 3010, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Welm</LastName>
<ForeName>Alana</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT, 84112, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wicha</LastName>
<ForeName>Max S</ForeName>
<Initials>MS</Initials>
<AffiliationInfo><Affiliation>Madeline and Sidney Forbes Professor of Oncology, Director, Forbes Institute for Cancer Discovery, NCRC 26-335S, SPC 2800 2800 Plymouth Rd, Ann Arbor, MI, 48109-2800, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Lewis</LastName>
<ForeName>Michael T</ForeName>
<Initials>MT</Initials>
<AffiliationInfo><Affiliation>The Lester and Sue Smith Breast Center, Departments of Molecular and Cellular Biology and Radiology, Baylor College of Medicine, Houston,, TX, 77030, USA. mtlewis@bcm.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>R01 CA112305</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01 CA172764</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01 CA173903</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01 CA129765</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>K08 CA164048</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01 CA140985</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>P30 CA034196</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>UL1 RR024992</GrantID>
<Acronym>RR</Acronym>
<Agency>NCRR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>P30 CA008748</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>P30 CA125123</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01 CA166422</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R21 CA185460</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01 CA101860</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>P50 CA058183</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>UL1 TR000448</GrantID>
<Acronym>TR</Acronym>
<Agency>NCATS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>U01 CA214172</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>U54 CA149196</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R21 CA187890</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>P50 CA186784</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>Netherlands</Country>
<MedlineTA>Cancer Metastasis Rev</MedlineTA>
<NlmUniqueID>8605731</NlmUniqueID>
<ISSNLinking>0167-7659</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Microsc Res Tech. 2001 Jan 15;52(2):224-30</RefSource>
<PMID Version="1">11169869</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nature. 2015 Feb 19;518(7539):422-6</RefSource>
<PMID Version="1">25470049</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2013 Nov;208 Suppl 2:S125-30</RefSource>
<PMID Version="1">24151318</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Mol Oncol. 2014 Mar;8(2):431-43</RefSource>
<PMID Version="1">24394560</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Blood. 1997 Jun 15;89(12):4307-16</RefSource>
<PMID Version="1">9192753</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2015 Nov;154(1):13-22</RefSource>
<PMID Version="1">26438141</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2006;1(1):206-14</RefSource>
<PMID Version="1">17406234</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer J Sci Am. 1996 Sep-Oct;2(5):291-300</RefSource>
<PMID Version="1">9166547</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res. 2002;4(4):155-64</RefSource>
<PMID Version="1">12100741</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Pathol. 1985 Sep;120(3):464-77</RefSource>
<PMID Version="1">2412448</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Curr Protoc Mouse Biol. 2013 Mar 01;3(1):21-9</RefSource>
<PMID Version="1">26069021</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2008 Dec;14(12):1384-9</RefSource>
<PMID Version="1">19029987</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2016 Jul;27(7):1190-8</RefSource>
<PMID Version="1">26912558</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2016 Jun 06;7:11908</RefSource>
<PMID Version="1">27264733</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Leukemia. 1998 Dec;12(12):2029-33</RefSource>
<PMID Version="1">9844934</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Methods Mol Biol. 2010;596:33-45</RefSource>
<PMID Version="1">19949919</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2010 Jun;121(2):301-9</RefSource>
<PMID Version="1">19603265</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Stem Cells. 2015 Jun;33(6):1696-704</RefSource>
<PMID Version="1">25694194</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cell. 2010 Jan 8;140(1):62-73</RefSource>
<PMID Version="1">20074520</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 1995 Jan-Feb;15(1):1-7</RefSource>
<PMID Version="1">7733618</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res. 2015 Jan 09;17:3</RefSource>
<PMID Version="1">25572662</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 1983 May;43(5):2223-39</RefSource>
<PMID Version="1">6831445</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Blood. 2002 Nov 1;100(9):3175-82</RefSource>
<PMID Version="1">12384415</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2007;8(5):R76</RefSource>
<PMID Version="1">17493263</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2010 Jan;1805(1):105-17</RefSource>
<PMID Version="1">19931353</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 1985 Mar;51(3):347-56</RefSource>
<PMID Version="1">3970811</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2015 May 30;6(15):12890-908</RefSource>
<PMID Version="1">25973541</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2010 May;121(1):53-64</RefSource>
<PMID Version="1">19593635</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2013 Aug 1;73(15):4885-97</RefSource>
<PMID Version="1">23737486</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2010 Jul;122(1):35-43</RefSource>
<PMID Version="1">19701706</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2012 Jun 15;72(12):3010-9</RefSource>
<PMID Version="1">22523036</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nature. 1994 Nov 3;372(6501):103-7</RefSource>
<PMID Version="1">7969402</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Expert Rev Mol Diagn. 2013 Mar;13(2):151-65</RefSource>
<PMID Version="1">23477556</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 1960 Apr;24:953-69</RefSource>
<PMID Version="1">13821714</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Blood. 2010 Jul 15;116(2):193-200</RefSource>
<PMID Version="1">20404133</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 1980 Oct;42(4):524-9</RefSource>
<PMID Version="1">6254552</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2007 Jul 1;13(13):3989-98</RefSource>
<PMID Version="1">17606733</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 1979 Dec;63(6):1331-7</RefSource>
<PMID Version="1">92586</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2012 Feb 21;109 (8):2766-71</RefSource>
<PMID Version="1">21768359</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Development. 2000 Jun;127(11):2269-82</RefSource>
<PMID Version="1">10804170</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur J Immunol. 1995 Feb;25(2):631-4</RefSource>
<PMID Version="1">7875225</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Contemp Top Lab Anim Sci. 2003 Nov;42(6):33-5</RefSource>
<PMID Version="1">14615958</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2007 Mar 15;67(6):2649-56</RefSource>
<PMID Version="1">17363585</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Care (Basel). 2016 Apr;11(2):108-15</RefSource>
<PMID Version="1">27239172</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2015 Sep 01;10(9):e0136851</RefSource>
<PMID Version="1">26325287</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2009 Mar 10;27(8):1160-7</RefSource>
<PMID Version="1">19204204</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Hum Immunol. 2009 May;70(5):325-30</RefSource>
<PMID Version="1">19236898</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Pathol. 2016 Nov;240(3):256-261</RefSource>
<PMID Version="1">27447842</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nature. 2014 Aug 14;512(7513):155-60</RefSource>
<PMID Version="1">25079324</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nature. 2011 Apr 7;472(7341):90-4</RefSource>
<PMID Version="1">21399628</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2012 Sep;135(2):415-32</RefSource>
<PMID Version="1">22821401</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 2015 Jan 1;121(1):8-16</RefSource>
<PMID Version="1">25043972</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2016 Jul 26;7(30):48206-48219</RefSource>
<PMID Version="1">27374081</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 1959 Jun;19(5):515-20</RefSource>
<PMID Version="1">13663040</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Arch Pathol Lab Med. 2014 Feb;138(2):241-56</RefSource>
<PMID Version="1">24099077</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2003 Jul 1;105(4):444-53</RefSource>
<PMID Version="1">12712433</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nature. 2000 Aug 17;406(6797):747-52</RefSource>
<PMID Version="1">10963602</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Cell. 2006 Dec;10(6):529-41</RefSource>
<PMID Version="1">17157792</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 1988 Mar 1;167(3):1016-33</RefSource>
<PMID Version="1">3280724</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Blood. 2013 Mar 21;121(12):e90-7</RefSource>
<PMID Version="1">23349390</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Genet Res. 1966 Dec;8(3):295-309</RefSource>
<PMID Version="1">5980117</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res. 2015 Feb 10;17:17</RefSource>
<PMID Version="1">25849559</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cell. 1995 Mar 10;80(5):813-23</RefSource>
<PMID Version="1">7889575</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Adv Exp Med Biol. 2016;882:169-89</RefSource>
<PMID Version="1">26987535</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 1971 Sep 1;134(3 Pt 1):681-92</RefSource>
<PMID Version="1">15776569</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nature. 2010 Apr 15;464(7291):999-1005</RefSource>
<PMID Version="1">20393555</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nature. 2009 Jun 18;459(7249):1005-9</RefSource>
<PMID Version="1">19421193</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2016 May 3;7(18):26107-19</RefSource>
<PMID Version="1">27034166</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4966-71</RefSource>
<PMID Version="1">15051869</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Biomed Pharmacother. 2005 Oct;59 Suppl 2:S375-9</RefSource>
<PMID Version="1">16507413</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res. 2009;11(5):R66</RefSource>
<PMID Version="1">19735549</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2012 Mar 22;366(12):1090-8</RefSource>
<PMID Version="1">22417201</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 2000 Jan 15;14(2):142-6</RefSource>
<PMID Version="1">10702024</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Discov. 2014 Sep;4(9):998-1013</RefSource>
<PMID Version="1">25185190</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Stem Cells. 2011 Jan;29(1):11-9</RefSource>
<PMID Version="1">21280155</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2016 Mar 08;11(3):e0151121</RefSource>
<PMID Version="1">26953790</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res. 2006;8(2):R21</RefSource>
<PMID Version="1">16611371</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2016 Mar;11(3):616</RefSource>
<PMID Version="1">26914320</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cell. 2012 May 25;149(5):994-1007</RefSource>
<PMID Version="1">22608083</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Cell. 2003 Jun;3(6):537-49</RefSource>
<PMID Version="1">12842083</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Curr Protoc Pharmacol. 2012 Dec;Chapter 14:Unit 14.22</RefSource>
<PMID Version="1">23258598</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Immunol. 1995 Jan 1;154(1):180-91</RefSource>
<PMID Version="1">7995938</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2002 Feb 1;62(3):917-23</RefSource>
<PMID Version="1">11830552</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2001 May 18;84(10):1424-31</RefSource>
<PMID Version="1">11355958</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Lett. 2014 Mar 1;344(1):13-9</RefSource>
<PMID Version="1">24513265</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Exp Metastasis. 1995 Jan;13(1):3-15</RefSource>
<PMID Version="1">7820953</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2014 Mar 1;74(5):1463-74</RefSource>
<PMID Version="1">24425047</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Mol Oncol. 2011 Feb;5(1):5-23</RefSource>
<PMID Version="1">21147047</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Discov. 2011 Jun;1(1):54-67</RefSource>
<PMID Version="1">22039576</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Curr Opin Immunol. 2010 Apr;22(2):231-7</RefSource>
<PMID Version="1">20144856</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neoplasia. 2015 Sep;17(9):735-41</RefSource>
<PMID Version="1">26476081</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2012 May 03;7(6):1024-41</RefSource>
<PMID Version="1">22555242</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Pathol. 1995 Apr;146(4):888-902</RefSource>
<PMID Version="1">7717456</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1992 Nov;12(11):5152-8</RefSource>
<PMID Version="1">1406687</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Pathol. 1996 Jan;148(1):313-9</RefSource>
<PMID Version="1">8546221</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):13081-6</RefSource>
<PMID Version="1">18723673</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2011 Oct 23;17(11):1514-20</RefSource>
<PMID Version="1">22019887</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2008 Apr 02;3(4):e1908</RefSource>
<PMID Version="1">18382681</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2016 Jun 16;11(6):e0157368</RefSource>
<PMID Version="1">27310713</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2007 Mar 1;67(5):2062-71</RefSource>
<PMID Version="1">17332335</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 1999 Dec;81(8):1328-34</RefSource>
<PMID Version="1">10604729</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2013 Sep 26;4(6):1116-30</RefSource>
<PMID Version="1">24055055</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2013 Dec;23(12):2115-25</RefSource>
<PMID Version="1">24056532</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Lett. 1981 Dec;14(3):309-16</RefSource>
<PMID Version="1">7332907</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2010 Sep;16(9):974-5</RefSource>
<PMID Version="1">20823880</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2010 Aug 16;5(8):e12180</RefSource>
<PMID Version="1">20808935</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 1980 Jan;40(1):95-100</RefSource>
<PMID Version="1">6243091</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Apr;32(4):364-72</RefSource>
<PMID Version="1">24633240</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2016 Aug;22(8):933-9</RefSource>
<PMID Version="1">27322743</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Lett. 1980 Aug;10(2):177-89</RefSource>
<PMID Version="1">7459836</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 1988 Jan;57(1):19-31</RefSource>
<PMID Version="1">3348947</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Biol Ther. 2009 Jun;8(11):1010-7</RefSource>
<PMID Version="1">19398888</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2008 May 7;100(9):672-9</RefSource>
<PMID Version="1">18445819</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Exp Cell Biol. 1979;47(4):281-93</RefSource>
<PMID Version="1">467773</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res. 2014 May 20;16(3):210</RefSource>
<PMID Version="1">25928070</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur J Cancer. 2004 Apr;40(6):845-51</RefSource>
<PMID Version="1">15120040</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nature. 1979 Mar 29;278(5703):451-3</RefSource>
<PMID Version="1">313007</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Immunol Immunother. 2007 Mar;56(3):271-85</RefSource>
<PMID Version="1">16819631</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cell Cycle. 2009 Aug;8(15):2317-8</RefSource>
<PMID Version="1">19625762</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Cell. 2013 Jul 8;24(1):120-9</RefSource>
<PMID Version="1">23845444</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cell Growth Differ. 1993 Jul;4(7):563-9</RefSource>
<PMID Version="1">8398896</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2013 Dec 15;73(24):7290-300</RefSource>
<PMID Version="1">24142344</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nature. 2009 Oct 8;461(7265):809-13</RefSource>
<PMID Version="1">19812674</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Mammary Gland Biol Neoplasia. 2000 Oct;5(4):379-91</RefSource>
<PMID Version="1">14973383</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nature. 2012 Apr 04;486(7403):395-9</RefSource>
<PMID Version="1">22495314</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Pathol. 1977 Nov;89(2):413-30</RefSource>
<PMID Version="1">200144</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trends Immunol. 2016 Jul;37(7):462-76</RefSource>
<PMID Version="1">27216414</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Mod Pathol. 1998 Feb;11(2):155-68</RefSource>
<PMID Version="1">9504686</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Mammary Gland Biol Neoplasia. 2016 Dec;21(3-4):99-109</RefSource>
<PMID Version="1">27680982</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2012 Jun 1;72(11):2705-13</RefSource>
<PMID Version="1">22467173</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 1985 Feb;45(2):584-90</RefSource>
<PMID Version="1">3967234</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 1988 May 15;41(5):713-9</RefSource>
<PMID Version="1">3366492</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Immunol. 1993 May 1;150(9):3817-24</RefSource>
<PMID Version="1">8473734</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Cell. 2006 Dec;10(6):515-27</RefSource>
<PMID Version="1">17157791</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Immunol Lett. 2012 Aug 30;146(1-2):1-7</RefSource>
<PMID Version="1">22507217</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Rev Drug Discov. 2010 Apr;9(4):253-4</RefSource>
<PMID Version="1">20369394</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cell Immunol. 1996 Aug 1;171(2):186-99</RefSource>
<PMID Version="1">8806787</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2015 Apr 1;21(7):1688-98</RefSource>
<PMID Version="1">25208879</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cell. 2012 Mar 2;148(5):873-85</RefSource>
<PMID Version="1">22385957</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nature. 2014 Oct 2;514(7520):54-8</RefSource>
<PMID Version="1">25079331</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):71-8</RefSource>
<PMID Version="1">17049443</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Cell. 2016 Mar 14;29(3):407-22</RefSource>
<PMID Version="1">26947176</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Cancer Res Clin Oncol. 1992;119(1):35-40</RefSource>
<PMID Version="1">1400563</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2006 Nov;12(11):1294-300</RefSource>
<PMID Version="1">17057710</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Rev Immunol. 2007 Feb;7(2):118-30</RefSource>
<PMID Version="1">17259968</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Cell. 2007 Mar;11(3):259-73</RefSource>
<PMID Version="1">17349583</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Cancer. 2014 Jan 23;5(2):156-65</RefSource>
<PMID Version="1">24563670</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res. 2014 Apr 07;16(2):R36</RefSource>
<PMID Version="1">24708766</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nature. 1983 Feb 10;301(5900):527-30</RefSource>
<PMID Version="1">6823332</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2014 Nov;24(11):1881-93</RefSource>
<PMID Version="1">25060187</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Cell. 2008 May;13(5):394-406</RefSource>
<PMID Version="1">18455123</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Prostate. 2015 May;75(6):585-92</RefSource>
<PMID Version="1">25585936</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 1978 Jan;41(1):239-44</RefSource>
<PMID Version="1">626933</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nature. 2012 Apr 18;486(7403):346-52</RefSource>
<PMID Version="1">22522925</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2007 Dec;8(12):1071-8</RefSource>
<PMID Version="1">18024211</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nature. 2012 Oct 4;490(7418):61-70</RefSource>
<PMID Version="1">23000897</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Endocrinol. 2006 Mar;188(3):589-601</RefSource>
<PMID Version="1">16522738</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nature. 2012 May 16;486(7403):400-4</RefSource>
<PMID Version="1">22722201</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Arch Pathol Lab Med. 2010 Jun;134(6):907-22</RefSource>
<PMID Version="1">20524868</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2011 Nov 15;108(46):18708-13</RefSource>
<PMID Version="1">22068913</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Discov. 2011 Nov;1(6):508-23</RefSource>
<PMID Version="1">22586653</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Dis. 2006-2007;26:139-47</RefSource>
<PMID Version="1">17473372</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2016 May 10;7:11479</RefSource>
<PMID Version="1">27161491</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Cell. 2008 Jan;13(1):23-35</RefSource>
<PMID Version="1">18167337</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res. 2010;12(5):R68</RefSource>
<PMID Version="1">20813035</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nature. 1988 Sep 15;335(6187):256-9</RefSource>
<PMID Version="1">2970594</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2009 Feb;19(2):167-77</RefSource>
<PMID Version="1">19056696</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2008 Jan 15;14(2):370-8</RefSource>
<PMID Version="1">18223211</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Chem. 2014 Jan;60(1):122-33</RefSource>
<PMID Version="1">24298072</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2015 Nov;21(11):1318-25</RefSource>
<PMID Version="1">26479923</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Cell Physiol. 1995 Apr;163(1):51-60</RefSource>
<PMID Version="1">7896900</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nature. 2012 Jun 20;486(7403):405-9</RefSource>
<PMID Version="1">22722202</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nature. 2007 Oct 4;449(7162):557-63</RefSource>
<PMID Version="1">17914389</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nature. 2005 Jul 28;436(7050):518-24</RefSource>
<PMID Version="1">16049480</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8</RefSource>
<PMID Version="1">12629218</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Adv Immunol. 2006;90:1-50</RefSource>
<PMID Version="1">16730260</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 1997 Jul 16;89(14):1059-65</RefSource>
<PMID Version="1">9230888</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2014 Jul 20;32(21):2255-69</RefSource>
<PMID Version="1">24868023</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 1993 Nov 3;85(21):1725-32</RefSource>
<PMID Version="1">8411256</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Curr Protoc Pharmacol. 2013 Mar;Chapter 14:Unit14.23</RefSource>
<PMID Version="1">23456611</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Cell. 2010 Nov 16;18(5):485-98</RefSource>
<PMID Version="1">21035406</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Blood. 1996 Nov 15;88(10):3731-40</RefSource>
<PMID Version="1">8916937</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cell. 1992 Mar 6;68(5):869-77</RefSource>
<PMID Version="1">1547488</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2009 Aug;15(8):907-13</RefSource>
<PMID Version="1">19648928</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2012 Oct;135(3):913-22</RefSource>
<PMID Version="1">22941572</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 1980 Apr 15;45(8):2160-5</RefSource>
<PMID Version="1">7370957</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2010 Feb 1;16(3):876-87</RefSource>
<PMID Version="1">20103682</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2005 May 15;174(10):6477-89</RefSource>
<PMID Version="1">15879151</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>BMC Cancer. 2003 Apr 24;3:13</RefSource>
<PMID Version="1">12713671</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2016 Aug 1;22(15):3764-73</RefSource>
<PMID Version="1">26957554</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cell. 2006 Jan 27;124(2):263-6</RefSource>
<PMID Version="1">16439202</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2014 Jul 1;32(19):2100-8</RefSource>
<PMID Version="1">24799487</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res. 2004;6(1):22-30</RefSource>
<PMID Version="1">14680482</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2014 Apr;11(4):396-8</RefSource>
<PMID Version="1">24633410</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Metastasis Rev. 2010 Jun;29(2):309-16</RefSource>
<PMID Version="1">20405169</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2011 Nov 1;129(9):2194-206</RefSource>
<PMID Version="1">21544806</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Science. 1976 Oct 1;194(4260):23-8</RefSource>
<PMID Version="1">959840</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2015 Jun 10;33(17 ):1974-82</RefSource>
<PMID Version="1">25605845</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Pathol. 1998 May;152(5):1299-311</RefSource>
<PMID Version="1">9588898</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res. 2016 Jan 27;18(1):13</RefSource>
<PMID Version="1">26818199</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Curr Drug Targets. 2010 Sep;11(9):1041-2</RefSource>
<PMID Version="1">20545615</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2012 Jun;133(2):595-606</RefSource>
<PMID Version="1">22002565</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res. 2016 Jun 28;18(1):68</RefSource>
<PMID Version="1">27349894</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74</RefSource>
<PMID Version="1">11553815</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Cell Biochem. 2006 Jul 1;98(4):966-80</RefSource>
<PMID Version="1">16795075</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2011 Jan 15;71(2):614-24</RefSource>
<PMID Version="1">21224357</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 1975 Dec;55(6):1461-6</RefSource>
<PMID Version="1">1206764</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 1996;39(1):69-86</RefSource>
<PMID Version="1">8738607</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>BioDrugs. 2009;23(5):277-87</RefSource>
<PMID Version="1">19754218</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Mol Oncol. 2007 Jun;1(1):84-96</RefSource>
<PMID Version="1">18516279</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004195" MajorTopicYN="Y">Disease Models, Animal</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D064593" MajorTopicYN="N">Heterografts</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016688" MajorTopicYN="N">Mice, Inbred NOD</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016513" MajorTopicYN="N">Mice, SCID</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009368" MajorTopicYN="N">Neoplasm Transplantation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D057170" MajorTopicYN="N">Translational Medical Research</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Breast cancer</Keyword>
<Keyword MajorTopicYN="N">Immunocompromised/immunodeficient mice</Keyword>
<Keyword MajorTopicYN="N">PDX consortium</Keyword>
<Keyword MajorTopicYN="N">Patient-derived xenograft</Keyword>
<Keyword MajorTopicYN="N">Translational research</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year>
<Month>12</Month>
<Day>01</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2016</Year>
<Month>12</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2017</Year>
<Month>11</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2016</Year>
<Month>12</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">28025748</ArticleId>
<ArticleId IdType="doi">10.1007/s10555-016-9653-x</ArticleId>
<ArticleId IdType="pii">10.1007/s10555-016-9653-x</ArticleId>
<ArticleId IdType="pmc">PMC5396460</ArticleId>
<ArticleId IdType="mid">NIHMS839391</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Australie</li>
<li>Canada</li>
<li>Espagne</li>
<li>France</li>
<li>Royaume-Uni</li>
<li>Suisse</li>
<li>États-Unis</li>
</country>
<region><li>Angleterre</li>
<li>Aquitaine</li>
<li>Canton de Vaud</li>
<li>Catalogne</li>
<li>Grand Manchester</li>
<li>Nouvelle-Aquitaine</li>
<li>État de New York</li>
<li>Île-de-France</li>
</region>
<settlement><li>Barcelone</li>
<li>Bordeaux</li>
<li>Lausanne</li>
<li>Manchester</li>
<li>Paris</li>
</settlement>
<orgName><li>Université de Manchester</li>
</orgName>
</list>
<tree><country name="États-Unis"><noRegion><name sortKey="Dobrolecki, Lacey E" sort="Dobrolecki, Lacey E" uniqKey="Dobrolecki L" first="Lacey E" last="Dobrolecki">Lacey E. Dobrolecki</name>
</noRegion>
<name sortKey="Airhart, Susie D" sort="Airhart, Susie D" uniqKey="Airhart S" first="Susie D" last="Airhart">Susie D. Airhart</name>
<name sortKey="Behbod, Fariba" sort="Behbod, Fariba" uniqKey="Behbod F" first="Fariba" last="Behbod">Fariba Behbod</name>
<name sortKey="Bult, Carol J" sort="Bult, Carol J" uniqKey="Bult C" first="Carol J" last="Bult">Carol J. Bult</name>
<name sortKey="Cai, Shirong" sort="Cai, Shirong" uniqKey="Cai S" first="Shirong" last="Cai">Shirong Cai</name>
<name sortKey="Dowst, Heidi" sort="Dowst, Heidi" uniqKey="Dowst H" first="Heidi" last="Dowst">Heidi Dowst</name>
<name sortKey="Ellis, Matthew J" sort="Ellis, Matthew J" uniqKey="Ellis M" first="Matthew J" last="Ellis">Matthew J. Ellis</name>
<name sortKey="Kabos, Peter" sort="Kabos, Peter" uniqKey="Kabos P" first="Peter" last="Kabos">Peter Kabos</name>
<name sortKey="Lewis, Michael T" sort="Lewis, Michael T" uniqKey="Lewis M" first="Michael T" last="Lewis">Michael T. Lewis</name>
<name sortKey="Li, Shunqiang" sort="Li, Shunqiang" uniqKey="Li S" first="Shunqiang" last="Li">Shunqiang Li</name>
<name sortKey="Mccoy, Aaron" sort="Mccoy, Aaron" uniqKey="Mccoy A" first="Aaron" last="Mccoy">Aaron Mccoy</name>
<name sortKey="Meric Bernstam, Funda" sort="Meric Bernstam, Funda" uniqKey="Meric Bernstam F" first="Funda" last="Meric-Bernstam">Funda Meric-Bernstam</name>
<name sortKey="Piwnica Worms, Helen" sort="Piwnica Worms, Helen" uniqKey="Piwnica Worms H" first="Helen" last="Piwnica-Worms">Helen Piwnica-Worms</name>
<name sortKey="Reis Filho, Jorge" sort="Reis Filho, Jorge" uniqKey="Reis Filho J" first="Jorge" last="Reis-Filho">Jorge Reis-Filho</name>
<name sortKey="Sartorius, Carol A" sort="Sartorius, Carol A" uniqKey="Sartorius C" first="Carol A" last="Sartorius">Carol A. Sartorius</name>
<name sortKey="Tu, Yizheng" sort="Tu, Yizheng" uniqKey="Tu Y" first="Yizheng" last="Tu">Yizheng Tu</name>
<name sortKey="Welm, Alana" sort="Welm, Alana" uniqKey="Welm A" first="Alana" last="Welm">Alana Welm</name>
<name sortKey="Wicha, Max S" sort="Wicha, Max S" uniqKey="Wicha M" first="Max S" last="Wicha">Max S. Wicha</name>
</country>
<country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Alferez, Denis G" sort="Alferez, Denis G" uniqKey="Alferez D" first="Denis G" last="Alferez">Denis G. Alferez</name>
</region>
<name sortKey="Clarke, Robert B" sort="Clarke, Robert B" uniqKey="Clarke R" first="Robert B" last="Clarke">Robert B. Clarke</name>
</country>
<country name="Canada"><noRegion><name sortKey="Aparicio, Samuel" sort="Aparicio, Samuel" uniqKey="Aparicio S" first="Samuel" last="Aparicio">Samuel Aparicio</name>
</noRegion>
</country>
<country name="Suisse"><noRegion><name sortKey="Bentires Alj, Mohamed" sort="Bentires Alj, Mohamed" uniqKey="Bentires Alj M" first="Mohamed" last="Bentires-Alj">Mohamed Bentires-Alj</name>
</noRegion>
<name sortKey="Brisken, Cathrin" sort="Brisken, Cathrin" uniqKey="Brisken C" first="Cathrin" last="Brisken">Cathrin Brisken</name>
<name sortKey="Scabia, Valentina" sort="Scabia, Valentina" uniqKey="Scabia V" first="Valentina" last="Scabia">Valentina Scabia</name>
<name sortKey="Sflomos, George" sort="Sflomos, George" uniqKey="Sflomos G" first="George" last="Sflomos">George Sflomos</name>
</country>
<country name="Espagne"><region name="Catalogne"><name sortKey="Gonzalez Suarez, Eva" sort="Gonzalez Suarez, Eva" uniqKey="Gonzalez Suarez E" first="Eva" last="Gonzalez-Suarez">Eva Gonzalez-Suarez</name>
</region>
</country>
<country name="France"><region name="Nouvelle-Aquitaine"><name sortKey="Iggo, Richard D" sort="Iggo, Richard D" uniqKey="Iggo R" first="Richard D" last="Iggo">Richard D. Iggo</name>
</region>
<name sortKey="Marangoni, Elisabetta" sort="Marangoni, Elisabetta" uniqKey="Marangoni E" first="Elisabetta" last="Marangoni">Elisabetta Marangoni</name>
<name sortKey="Poupon, Marie France" sort="Poupon, Marie France" uniqKey="Poupon M" first="Marie-France" last="Poupon">Marie-France Poupon</name>
</country>
<country name="Australie"><noRegion><name sortKey="Lindeman, Geoffrey J" sort="Lindeman, Geoffrey J" uniqKey="Lindeman G" first="Geoffrey J" last="Lindeman">Geoffrey J. Lindeman</name>
</noRegion>
<name sortKey="Vaillant, Francois" sort="Vaillant, Francois" uniqKey="Vaillant F" first="François" last="Vaillant">François Vaillant</name>
<name sortKey="Visvader, Jane E" sort="Visvader, Jane E" uniqKey="Visvader J" first="Jane E" last="Visvader">Jane E. Visvader</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004094 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 004094 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Asie |area= AustralieFrV1 |flux= Ncbi |étape= Merge |type= RBID |clé= pubmed:28025748 |texte= Patient-derived xenograft (PDX) models in basic and translational breast cancer research. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:28025748" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \ | NlmPubMed2Wicri -a AustralieFrV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |